Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | X022985 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
No additional AEs were reported; Medical assistant reported that a patient received an expired MMR II vaccine on 7/14/2025.; This spontaneous report was received from a healthcare professional regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 14-JUL-2025, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) administered as the first dose for prophylaxis (lot number reported as X022985, which has been verified as valid, expiration date reported and validated as 08-JUN-2025) (dose, route of administration, and anatomical site of injection were not reported). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were not reported) (Expired product administered). No additional adverse events were reported.